The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Akinsanya Karen since 2020.
This trader's CIK number is 1797672.
At the time of last reporting, Akinsanya Karen was the President of R&D, Therapeutics of Schrodinger, Inc.. (stock ticker symbol SDGR).
Also see all insider trading activities at Schrodinger, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | SDGR | 0 | $0 | 16,723 | $419,312 | 16,723 | $51,339 |
| 2021 | SDGR | 0 | $0 | 40,525 | $2,344,281 | 40,525 | $321,055 |
| 2020 | SDGR | 0 | $0 | 36,786 | $2,645,391 | 36,786 | $113,433 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-04-14 | SDGR | Option Ex | 16,723 | 3.07 | 51,339 |
| 2025-04-14 | SDGR | Sale | 16,723 | 25.07 | 419,312 |
| 2021-10-15 | SDGR | Option Ex | 1,393 | 4.34 | 6,045 |
| 2021-10-15 | SDGR | Sale | 1,393 | 55.75 | 77,659 |
| 2021-09-15 | SDGR | Option Ex | 1,394 | 4.34 | 6,049 |
| 2021-09-15 | SDGR | Sale | 1,394 | 61.13 | 85,215 |
| 2021-08-16 | SDGR | Option Ex | 37,738 | 8.19 | 308,961 |
| 2021-08-16 | SDGR | Sale | 37,738 | 57.80 | 2,181,407 |
| 2020-12-18 | SDGR | Sale | 13,377 | 80.00 | 1,070,160 |
| 2020-12-18 | SDGR | Option Ex | 13,377 | 3.22 | 43,073 |
| 2020-08-17 | SDGR | Option Ex | 3,344 | 2.92 | 9,764 |
| 2020-08-17 | SDGR | Sale | 3,344 | 68.91 | 230,435 |
| 2020-08-12 | SDGR | Option Ex | 20,065 | 3.02 | 60,596 |
| 2020-08-12 | SDGR | Sale | 20,065 | 67.02 | 1,344,796 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Akinsanya Karen (President of R&D, Therapeutics of Schrodinger, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.